
|Videos|August 11, 2022
Clinical Implications of Using Genomic Testing Results in Prostate Cancer Risk-Stratification and Treatment Selection
Author(s)Stephen J. Freedland, MD
Dr Freedland discusses the clinical implications of using genomic test results for management of patients with prostate cancer.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5













